Clinical Efficacy of Non-Statin Treatment Options in ASCVD

Focusing on PCSK9 inhibitors, inclisiran, and bempedoic acid, the panel compares treatment efficacy and outlines patient factors that influence treatment decisions.

EP: 1.How Often Do Patients with ASCVD Achieve Target LDL-C?

EP: 2.Gaps Between Guidelines and Clinical Practice Patterns in ASCVD

EP: 3.Comparing the ACC/AHA and ESC/EAS Cholesterol Management Guidelines

EP: 4.Key Barriers in Implementing Guideline-Directed Cholesterol Treatment

EP: 5.Evaluating Non-Statin Lipid-Lowering Therapies in ASCVD

Now Viewing

EP: 6.Clinical Efficacy of Non-Statin Treatment Options in ASCVD

EP: 7.Non-Statin Therapies: Cost Effectiveness and Clinical Evidence Gaps

EP: 8.Persistence and Discontinuation Rates for Non-Statin Therapies in ASCVD

EP: 9.The Role of Pharmacists in Treating Very High-Risk ASCVD

EP: 10.Valuable Metrics and Improving Adherence in Patients With ASCVD

EP: 11.Successful Collaborative Care Strategies for Pharmacists

Related Videos

Related Content

Advertisement

May 21st 2025

Study Finds Increased Risk of CVD Among Women With History of Infertilty

Gillian McGovern, Associate Editor

May 20th 2025

Pharmacist Involvement in Clinical Research and the FINEARTS-HF Trial

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP Aislinn Antrim, Managing Editor

May 12th 2025

Children Born to Mothers With Cardiometabolic Issues Before or During Pregnancy Face Increased Risk of Childhood, Adolescent Hypertension

Gillian McGovern, Associate Editor

May 12th 2025

Insights from a Pharmacy Times Peer Exchange: Emerging ADCs and Real-World Management

Alexandra Gerlach, Associate Editor

May 7th 2025

Low-Dose Chlorthalidone Granted FDA Approval for Treatment of Adults With Hypertension

Luke Halpern, Assistant Editor

May 7th 2025

Study: Predictive CAD Model Outperforms Standard Practice in Estimating Individual Risk

Gillian McGovern, Associate Editor

Related Content

Advertisement

May 21st 2025

Study Finds Increased Risk of CVD Among Women With History of Infertilty

Gillian McGovern, Associate Editor

May 20th 2025

Pharmacist Involvement in Clinical Research and the FINEARTS-HF Trial

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP Aislinn Antrim, Managing Editor

May 12th 2025

Children Born to Mothers With Cardiometabolic Issues Before or During Pregnancy Face Increased Risk of Childhood, Adolescent Hypertension

Gillian McGovern, Associate Editor

May 12th 2025

Insights from a Pharmacy Times Peer Exchange: Emerging ADCs and Real-World Management

Alexandra Gerlach, Associate Editor

May 7th 2025

Low-Dose Chlorthalidone Granted FDA Approval for Treatment of Adults With Hypertension

Luke Halpern, Assistant Editor

May 7th 2025

Study: Predictive CAD Model Outperforms Standard Practice in Estimating Individual Risk

Gillian McGovern, Associate Editor